These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Regenerative medicine: the emergence of an industry. Nerem RM J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S771-5. PubMed ID: 20843840 [TBL] [Abstract][Full Text] [Related]
43. California: 'the Stem Cell State'. Interview with Jonathan Thomas. Thomas J Regen Med; 2011 Nov; 6(6 Suppl):113-5. PubMed ID: 21999272 [TBL] [Abstract][Full Text] [Related]
44. Personal profile: interview with Michael Rae. Interview by Vicki Glaser. Rae M Rejuvenation Res; 2011 Feb; 14(1):95-7. PubMed ID: 21329454 [No Abstract] [Full Text] [Related]
45. Expanding horizons of cellular plasticity in regenerative medicine. Sen CK Am J Pathol; 2015 Oct; 185(10):2592-5. PubMed ID: 26435411 [TBL] [Abstract][Full Text] [Related]
46. Regenerative Medicine in the 21st Century: Advances in Engineering, Chemistry, Biology and Medicine Revolutionize Healthcare. Zeugolis DI; Pandit A Adv Healthc Mater; 2015 Nov; 4(16):2324-5. PubMed ID: 26767737 [No Abstract] [Full Text] [Related]
47. In the Spotlight: Tissue and Molecular Engineering. Desai TA IEEE Rev Biomed Eng; 2008; 1():21-2. PubMed ID: 22274897 [TBL] [Abstract][Full Text] [Related]
50. Cloning special: Dolly: a hard act to follow. Check E Nature; 2007 Feb; 445(7130):802. PubMed ID: 17314940 [No Abstract] [Full Text] [Related]
51. Regenerative medicine: Materials in a cellular world. Hunt JA Nat Mater; 2008 Aug; 7(8):617-8. PubMed ID: 18654587 [No Abstract] [Full Text] [Related]
52. The first stem cell-based tissue-engineered organ replacement: implications for regenerative medicine and society. Hollander A; Macchiarini P; Gordijn B; Birchall M Regen Med; 2009 Mar; 4(2):147-8. PubMed ID: 19317632 [No Abstract] [Full Text] [Related]
53. An interview with Martin Rosenberg, Ph.D. Interviewed by Vicki Glaser. Rosenberg M Assay Drug Dev Technol; 2009 Dec; 7(6):537-43. PubMed ID: 20035618 [No Abstract] [Full Text] [Related]
54. Personal profile: interview with James Joseph, Ph.D. Interview by Vicki Glaser. Joseph J Rejuvenation Res; 2009 Dec; 12(6):475-8. PubMed ID: 20041743 [No Abstract] [Full Text] [Related]
55. Introduction to regenerative medicine and tissue engineering. Stoltz JF; Decot V; Huseltein C; He X; Zhang L; Magdalou J; Li YP; Menu P; Li N; Wang YY; de Isla N; Bensoussan D Biomed Mater Eng; 2012; 22(1-3):3-16. PubMed ID: 22766697 [TBL] [Abstract][Full Text] [Related]
56. Interview with Kevin Warwick, D.Sc. Interview by Vicki Glaser. Warwick K Rejuvenation Res; 2008 Dec; 11(6):1079-82. PubMed ID: 19119864 [No Abstract] [Full Text] [Related]
57. Chemical control of stem cell fate and developmental potential. Lyssiotis CA; Lairson LL; Boitano AE; Wurdak H; Zhu S; Schultz PG Angew Chem Int Ed Engl; 2011 Jan; 50(1):200-42. PubMed ID: 21184400 [TBL] [Abstract][Full Text] [Related]